Skip to content


  • Poster presentation
  • Open Access

Central statistical monitoring in multicentre clinical trials: developing statistical approaches for analysing key risk indicators

  • 1,
  • 1,
  • 1 and
  • 1
Trials201314 (Suppl 1) :P139

  • Published:


  • Public Health
  • Clinical Trial
  • Patient Safety
  • Statistical Approach
  • Statistical Monitoring


Central statistical monitoring (CSM) can identify trial misconduct, and help to prioritise on-site visits and additional training. Key risk indicators (KRIs) focus CSM on variables most likely to affect study reliability or patient safety. We developed the use of robust minimum covariance determinant (MCD) distances to detect outlying centres in the context of KRI analyses.


Initially, a summary statistic (e.g. mean) describing the KRI is calculated for each centre and robust MCD-based distances are calculated by the FAST-MCD algorithm (Rousseeuw, 1999). For each KRI, robust estimates of the multivariate location and scatter are defined by minimizing the determinant of the covariance matrix and generalized distances, , are calculated. The distances follow a distribution (where n is the multivariate dimension) and define corresponding p-values. Outliers are defined as centres with p-values below a pre-defined threshold (e.g. p<0.05). This method can be used for univariate and multivariate KRIs. Furthermore, p-values can be combined across KRIs to form a single score. We provide empirical examples and graphical displays of univariate and multivariate KRI analyses undertaken using this robust MCD distance approach based on a large-scale multicentre cardiovascular trial.


Robust MCD distances offer a flexible approach for analysing both univariate and multivariate KRIs and can be implemented in standard statistical software.

Authors’ Affiliations

Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK


© Valdes-Marquez et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.